Further Clinical Studies with an Aldose Reductase Inhibitor in Diabetic Neuropathy

Diabetic Medicine

Volumn 10, Issue 2 S, 1993, Pages 35S-38S

  van Gerven, J M A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aldose reductase inhibitor; Clinical trials; Diabetic neuropathy

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; TOLRESTAT;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; HUMAN; NERVE CONDUCTION; PRIORITY JOURNAL;

ALDEHYDE REDUCTASE; COMPARATIVE STUDY; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMAN; MALE; MIDDLE AGE; NAPHTHALENES; NEURAL CONDUCTION;

EID: 0027319090     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.1993.tb00196.x     Document Type: Article

References (8)

1. Effects of pancreatic transplantation on diabetic polyneuropathy
2. The natural course of peripheral and autonomic neural function during the first two years after the diagnosis of type 1 diabetes mellitus
3. The prevalence of diabetic polyneuropathy in patients attending UK hospital clinics
4. Regeneration and repair of myelinated fibres in sural‐nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil
5. Acute painful diabetic neuropathy precipitated by strict glycaemic control
6. Rapid screening for peripheral neuropathy: a field study with the Optacon
7. 1990. Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy
8. Pain perception in diabetic neuropathy